New Database Could Improve Detection of Designer Drugs in Clinical Testing
Researchers develop computational approach to predict mass spectra for unknown psychoactive substances and their metabolites.
Researchers develop computational approach to predict mass spectra for unknown psychoactive substances and their metabolites.
The center will deploy PathAI’s AISight Dx platform across its pathology programs to enhance diagnostic accuracy, support research, and advance AI integration in cancer care.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
The newly appointed scientific and medical experts will guide product development, research, regulatory planning, and commercialization.
The collaboration integrates Modella AI’s research-use only pathology assistant with Techcyte’s cloud-based platform.
As labs aim to minimize disruptions, they are increasingly investing in strategies focused on resilience and rapid recovery.
Company sees back-to-back record months in June and July, reaffirms forecast of 3X year-over-year revenue growth for noninvasive lung cancer diagnostic.
The Oak Ridge, Tennessee-based company's next-generation analyzer delivers results three times faster than its predecessor while maintaining laboratory-grade diagnostic precision.
UK diagnostics developer signs with multi-site laboratory group to scale commercial launch of early-stage lung cancer biomarker test across the United States.
New research suggests standard drug tests may miss low-level exposure in children—potentially sending them back into unsafe home environments—and suggests an alternative.
Bruker's MALDI Biotyper sirius and sirius one systems have received the ACT Label from My Green Lab, recognizing responsible design.
Community Direct DX, Scienetix, and Advanta Genetics R&D combine with $30 million in funding to create a vertically integrated PCR testing platform.
Labcorp and NOWDiagnostics have partnered to distribute free First to Know Syphilis Test kits to public health organizations nationwide.
Many clinical laboratories are using outdated urine analyzers, which may affect efficiency and data accuracy.